We are live on
!
Find out more
JSP
Jackson Square Partners Portfolio holdings
AUM
$247M
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter
Est. Return
-2.53%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$19.3B
AUM Growth
-$2.98B
(-13%)
Cap. Flow
-$2.21B
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
39.78%
Holding
91
New
4
Increased
27
Reduced
54
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$219M |
| 2 |
IQVIA
IQV
|
+$93.6M |
| 3 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$48.4M |
| 4 |
LendingTree
TREE
|
+$28.6M |
| 5 |
Paycom
PAYC
|
+$24.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$365M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$276M |
| 3 |
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
|
+$162M |
| 4 |
Visa
V
|
+$137M |
| 5 |
CELG
Celgene Corp
CELG
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.09% |
| 2 | Healthcare | 17.61% |
| 3 | Technology | 17.04% |
| 4 | Communication Services | 16.99% |
| 5 | Consumer Discretionary | 13.34% |
Similar funds
OIA
SRC
TCB
MTWM
SSW
WS
FC
KSWA
Jackson Square Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Jackson Square Partners held 91 positions worth $19.3B, down 13% from $22.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jackson Square Partners withdrew a net $2.21B in Q4 2016, closing 6 positions and reducing 54 holdings. Its most notable exit was Novo Nordisk, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jackson Square Partners opened a new position in Charles Schwab worth $242M.
- Jackson Square Partners's largest Q4 2016 buy was Charles Schwab: 6,126,457 shares worth $242M.
- Jackson Square Partners added most to IQVIA in Q4 2016, an estimated $93.6M increase.
- Jackson Square Partners's biggest Q4 2016 reduction was Qualcomm, cutting an estimated $365M.
- Jackson Square Partners fully exited Novo Nordisk in Q4 2016, selling an estimated $276M.
- Jackson Square Partners's ten largest holdings make up 40% of its $19.3B portfolio in Q4 2016.
- Jackson Square Partners opened 4 new positions and closed 6 in Q4 2016.
- Jackson Square Partners's portfolio value fell 13% quarter-over-quarter to $19.3B.
Based on Jackson Square Partners's 13F filing for Q4 2016, filed 13 Feb 2017.